Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Pieter Vermeersch and Emmanuel André.
Pieter Vermeersch
Connection Strength
1.974
Emmanuel André
  1. How the European in vitro diagnostic regulation could negatively impact the European response to the next pandemic: an urgent call for action before May 2022. Clin Microbiol Infect. 2021 08; 27(8):1074-1075.
    View in: PubMed
    Score: 0.944
  2. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J Clin Virol. 2021 03; 136:104765.
    View in: PubMed
    Score: 0.233
  3. Immunoassays for anti-SARS-CoV-2 antibodies: recent insights. Lancet Infect Dis. 2021 05; 21(5):e120.
    View in: PubMed
    Score: 0.228
  4. Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2. Clin Chem Lab Med. 2020 09 25; 58(10):e197-e199.
    View in: PubMed
    Score: 0.226
  5. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clin Microbiol Infect. 2020 Nov; 26(11):1557.e1-1557.e7.
    View in: PubMed
    Score: 0.224
  6. Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection by a Phylogenetically Distinct Strain. Clin Infect Dis. 2021 07 15; 73(2):354-356.
    View in: PubMed
    Score: 0.060
  7. Comparison of the Quantitative DiaSorin Liaison Antigen Test to Reverse Transcription-PCR for the Diagnosis of COVID-19 in Symptomatic and Asymptomatic Outpatients. J Clin Microbiol. 2021 06 18; 59(7):e0037421.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.